Arcutis Biotherapeutics (ARQT)
Nasdaq • ARQT • US03969K1088
ORTEX Data Highlights
ORTEX Data Highlights
As of Oct 21, 2026, ORTEX estimated 23.1% of free float sold short, 8.7 days to cover, cost to borrow 0.42%. Sign up for live short interest data.
Market Cap
4.28b USD | # 2731 in US
Volume
2.51m shares | 67.25m USD
Shares Outstanding
125.69m
Free Float Shares
74.64% | 93.82m
